Search Results

You are looking at 31 - 40 of 491 items for :

  • Refine by Access: Content accessible to Me x
Clear All
Full access

Rachana Yendala, Kyaw Thein, Sriman Swarup, Anita Sultan, Somedeb Ball, Miguel Quirch, Myo H. Zaw, Yin M. Myat, and Catherine Jones

Background: Pain, fatigue, hot flushes, and rash significantly contribute to quality of life in breast cancer patients undergoing chemotherapy. Hormone receptor-positive breast cancer is a common entity among women worldwide. In cancer cells, CDK4

Full access

Janet L. Abrahm

also core palliative care skills, as are self-care and prevention of compassion fatigue (see later discussion). Finally, fellows should know when to consult a psychiatrist or palliative care expert. As Von Roenn and Temel 34 recommend, “When the

Full access

Miguel Quirch, Sriman Swarup, Anita Sultan, Wai L. Thein, Zayar M. Oo, Nyein H. Yu, Myo H. Zaw, Donald P. Quick, and Kyaw Z. Thein

.565–1.168; P =.261); neutropenia, 0.956 (95% CI: 0.720–1.268; P =.754); thrombocytopenia, 1.054 (95% CI: 0.450–2.470; P =.904); fatigue, 0.896 (95% CI: 0.761–1.056; P =.192); pyrexia, 1.123 (95% CI: 0.893–1.413; P =.322); and arthralgia, 1.863 (95% CI: 1

Full access

Neil M. Schultz, Eleanor O. Caplan, Sam Wilson, Richard Sheer, and Brandon T. Suehs

Therapy-Fatigue (FACIT-Fatigue). Higher scores indicated higher HRQoL on all surveys, except the HDs scale, where higher numbers indicated lower HRQoL (ie, unhealthy days). Pearson correlations with SF-36 and HDs measures and SCA and FACIT-Fatigue were

Full access

Jennifer M. Hinkel, Edward C. Li, and Stephen L. Sherman

from the malignancy itself. Anemia not only contributes to cancer-related fatigue and other quality of life (QoL) issues but also affects prognosis. From the operational perspective, a patient with cancer who is also anemic may consume more laboratory

Full access

Jamie M. Jacobs, Molly E. Ream, Nicole Pensak, Lauren E. Nisotel, Joel N. Fishbein, James J. MacDonald, Joanne Buzaglo, Inga T. Lennes, Steven A. Safren, William F. Pirl, Jennifer S. Temel, and Joseph A. Greer

-item Multidimensional Scale of Perceived Social Support (MSPSS), 22 with higher scores indicating greater perceived support. Fatigue The severity of cancer-related fatigue and its impact on functioning in the past 24 hours was measured using the 10

Full access

Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Wendy Demark-Wahnefried, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Grace H. Ku, Elizabeth Kvale, Terry S. Langbaum, Kristin Leonardi-Warren, Mary S. McCabe, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Javid J. Moslehi, Tracey O'Connor, Linda Overholser, Electra D. Paskett, Muhammad Raza, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole R. McMillian, and Deborah A. Freedman-Cass

play an important role in cognitive deficits after chemotherapy treatment. 2 , 5 , 13 , 29 , 30 In addition, fatigue and depression, common in cancer survivors, may negatively influence cognitive function, although several studies have found that

Full access

Camilla Zimmermann, Ashley Pope, Breffni Hannon, Monika K. Krzyzanowska, Gary Rodin, Madeline Li, Doris Howell, Jennifer J. Knox, Natasha B. Leighl, Srikala Sridhar, Amit M. Oza, Rebecca Prince, Stephanie Lheureux, Aaron R. Hansen, Anne Rydall, Brittany Chow, Leonie Herx, Christopher M. Booth, Deborah Dudgeon, Neesha Dhani, Geoffrey Liu, Philippe L. Bedard, Jean Mathews, Nadia Swami, and Lisa W. Le

every outpatient visit using the ESAS-r, with targeted EPC referral according to an algorithm based on symptom severity ( Figure 1 ). The ESAS-r assesses the severity of 9 common cancer symptoms (pain, fatigue, drowsiness, nausea, anxiety, depression

Full access

Tarek Haykal, Babikir Kheiri, Varun Samji, Yazan Zayed, Ragheed Al-Dulaimi, Inderdeep Gakhal, Areeg Bala, Jason Sotzen, Ahmed Abdalla, and Ghassan Bachuwa

Foundation, Vienna, Austria). Results: We included 8 RCTs, with a total of 4,106 patients. The mean age was 62, with 66.44% males. Any grade AEs were reported in 72% of patients with the following frequencies: fatigue, 44%; diarrhea, 38%; nausea, 31%; hand

Full access

Oxana Palesh, Arianna Aldridge-Gerry, Ayhan Ulusakarya, Elisabet Ortiz-Tudela, Lucile Capuron, and Pasquale F. Innominato

. For clinical diagnosis, these difficulties are typically associated with daytime impairment, such as fatigue or excessive sleepiness at least 3 times a week for 30 minutes or more for at least 1 month. Nearly 80% of women undergoing chemotherapy for